Development of Magnetic Resonance (MR) Simulation for Treatment Planning

Completed

• Conditions: Healthy

• Registration Number: NCT00314496
• Lead Sponsor: AHS Cancer Control Alberta

Brief Summary

Retrospectively have access to MR images of patients to develop software that:

1. segment images

2. convert MR values to electron density and then

3. entered into a dose calculation system

The project involves software development of data that is already available. No intervention is made at this point.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09
• Study First Submitted: 2006-04-11
• Study First Submitted QC: 2006-04-13
• Study First Posted: 2006-04-14
• Primary Completion: 2009-11
• Study Completion: 2009-11
• Status Verified: 2012-01
• Last Update Submitted: 2016-02-24
• Last Update Posted: 2016-02-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Subject 18 years of age and older

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Cross Cancer Institute; 🇨🇦 Edmonton, Alberta, Canada